BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 26444253)

  • 1. Analysis of MDM2 Amplification in 43 Endometrial Stromal Tumors: A Potential Diagnostic Pitfall.
    Schoolmeester JK; Sciallis AP; Greipp PT; Hodge JC; Dal Cin P; Keeney GL; Nucci MR
    Int J Gynecol Pathol; 2015 Nov; 34(6):576-83. PubMed ID: 26444253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Values of JAZF1 gene rearrangement detected by fluorescence in-situ hybridization in diagnosis of endometrial stromal tumours].
    Bai QM; Chang B; Tu XY; Bi R; Cheng YF; Huang D; Zhu XL; Wu LJ; Zhang X; Zhou XY; Yang WT
    Zhonghua Bing Li Xue Za Zhi; 2017 Nov; 46(11):769-774. PubMed ID: 29136690
    [No Abstract]   [Full Text] [Related]  

  • 3. JAZF1, YWHAE and BCOR gene translocation in primary extrauterine low-grade and high-grade endometrial stromal sarcomas.
    Sun L; Zhao W; Zhao Z; Zhu Y
    Histopathology; 2022 Apr; 80(5):809-819. PubMed ID: 34843125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial stromal sarcomas with BCOR-rearrangement harbor MDM2 amplifications.
    Kommoss FK; Chang KT; Stichel D; Banito A; Jones DT; Heilig CE; Fröhling S; Sahm F; Stenzinger A; Hartmann W; Mechtersheimer G; Sinn HP; Schmidt D; Kommoss F; von Deimling A; Koelsche C
    J Pathol Clin Res; 2020 Jul; 6(3):178-184. PubMed ID: 32352245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas?
    Le Guellec S; Chibon F; Ouali M; Perot G; Decouvelaere AV; Robin YM; Larousserie F; Terrier P; Coindre JM; Neuville A
    Am J Surg Pathol; 2014 Mar; 38(3):293-304. PubMed ID: 24525499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Cytogenetic Analysis of JAZF1, PHF1, and YWHAE in Endometrial Stromal Tumors: Discovery of Genetic Complexity by Fluorescence in Situ Hybridization.
    Hodge JC; Bedroske PP; Pearce KE; Sukov WR
    J Mol Diagn; 2016 Jul; 18(4):516-26. PubMed ID: 27154512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of fluorescence in-situ hybridization in monomorphic endometrial stromal neoplasms and their histological mimics: a review of 49 cases.
    Stewart CJ; Leung YC; Murch A; Peverall J
    Histopathology; 2014 Oct; 65(4):473-82. PubMed ID: 24592973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of known gene rearrangements in endometrial stromal tumors.
    Chiang S; Ali R; Melnyk N; McAlpine JN; Huntsman DG; Gilks CB; Lee CH; Oliva E
    Am J Surg Pathol; 2011 Sep; 35(9):1364-72. PubMed ID: 21836477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria.
    Mariño-Enríquez A; Fletcher CD; Dal Cin P; Hornick JL
    Am J Surg Pathol; 2010 Aug; 34(8):1122-31. PubMed ID: 20588177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical value of fluorescence
    Wang W; Li X; Liu P; Dong Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):228-233. PubMed ID: 37042132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overlapping features between dedifferentiated liposarcoma and undifferentiated high-grade pleomorphic sarcoma.
    Chung L; Lau SK; Jiang Z; Loera S; Bedel V; Ji J; Weiss LM; Chu PG
    Am J Surg Pathol; 2009 Nov; 33(11):1594-600. PubMed ID: 19574885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of MDM2 Fluorescence In Situ Hybridization and Immunohistochemistry in Distinguishing Dedifferentiated Liposarcoma From Other High-grade Sarcomas.
    Song MJ; Cho KJ; Lee JS; Song JS
    Appl Immunohistochem Mol Morphol; 2017; 25(10):712-719. PubMed ID: 27028243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR.
    Sirvent N; Coindre JM; Maire G; Hostein I; Keslair F; Guillou L; Ranchere-Vince D; Terrier P; Pedeutour F
    Am J Surg Pathol; 2007 Oct; 31(10):1476-89. PubMed ID: 17895748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-grade endometrial stromal sarcomas: a clinicopathologic study of a group of tumors with heterogenous morphologic and genetic features.
    Sciallis AP; Bedroske PP; Schoolmeester JK; Sukov WR; Keeney GL; Hodge JC; Bell DA
    Am J Surg Pathol; 2014 Sep; 38(9):1161-72. PubMed ID: 25133706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential diagnosis of atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: utility of p16 in combination with MDM2 and CDK4 immunohistochemistry.
    Kammerer-Jacquet SF; Thierry S; Cabillic F; Lannes M; Burtin F; Henno S; Dugay F; Bouzillé G; Rioux-Leclercq N; Belaud-Rotureau MA; Stock N
    Hum Pathol; 2017 Jan; 59():34-40. PubMed ID: 27597521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Undifferentiated Uterine Sarcomas Represent Under-Recognized High-grade Endometrial Stromal Sarcomas.
    Cotzia P; Benayed R; Mullaney K; Oliva E; Felix A; Ferreira J; Soslow RA; Antonescu CR; Ladanyi M; Chiang S
    Am J Surg Pathol; 2019 May; 43(5):662-669. PubMed ID: 30789359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of fluorescence in situ hybridization to detect MDM2 amplification in liposarcomas and their morphological mimics.
    Kimura H; Dobashi Y; Nojima T; Nakamura H; Yamamoto N; Tsuchiya H; Ikeda H; Sawada-Kitamura S; Oyama T; Ooi A
    Int J Clin Exp Pathol; 2013; 6(7):1306-16. PubMed ID: 23826411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of fluorescence in situ hybridization (FISH) in determining DNA damage-inducible transcript 3 (DDIT3) amplification in dedifferentiated liposarcomas - an important diagnostic pitfall.
    Kuczkiewicz-Siemion O; Wiśniewski P; Dansonka-Mieszkowska A; Grabowska-Kierył M; Olszewska K; Goryń T; Prochorec-Sobieszek M; Rutkowski P; Szumera-Ciećkiewicz A
    Pathol Res Pract; 2021 Sep; 225():153555. PubMed ID: 34325315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel, recurrent MBTD1-CXorf67 fusion in low-grade endometrial stromal sarcoma.
    Dewaele B; Przybyl J; Quattrone A; Finalet Ferreiro J; Vanspauwen V; Geerdens E; Gianfelici V; Kalender Z; Wozniak A; Moerman P; Sciot R; Croce S; Amant F; Vandenberghe P; Cools J; Debiec-Rychter M
    Int J Cancer; 2014 Mar; 134(5):1112-22. PubMed ID: 23959973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial stromal tumors: the new WHO classification.
    Conklin CM; Longacre TA
    Adv Anat Pathol; 2014 Nov; 21(6):383-93. PubMed ID: 25299308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.